SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001439222-21-000052
Filing Date
2021-06-02
Accepted
2021-06-02 16:07:55
Documents
1
Period of Report
2021-05-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_162266445283384.html 4  
1 FORM 4 wf-form4_162266445283384.xml 4 5500
  Complete submission text file 0001439222-21-000052.txt   6944
Mailing Address C/O BIOGEN IDEC INC. 14 CAMBRIDGE CENTER CAMBRIDGE MA 02142
Business Address
Clancy Paul J (Reporting) CIK: 0001409601 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36014 | Film No.: 21989157

Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Issuer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations